Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
42M
-
Shares change
-
+448K
-
Total reported value, excl. options
-
$345M
-
Value change
-
+$5.51M
-
Put/Call ratio
-
0.99
-
Number of buys
-
84
-
Number of sells
-
-78
-
Price
-
$8.21
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q2 2025
195 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42M shares
of 51.1M outstanding shares and own 82.2% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.76M shares), Redmile Group, LLC (4.78M shares), JPMORGAN CHASE & CO (3.85M shares), VANGUARD GROUP INC (3.42M shares), STATE STREET CORP (1.84M shares), GOLDMAN SACHS GROUP INC (1.78M shares), GEODE CAPITAL MANAGEMENT, LLC (1.13M shares), DIMENSIONAL FUND ADVISORS LP (1.12M shares), MORGAN STANLEY (995K shares), and AQR CAPITAL MANAGEMENT LLC (930K shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.